isabelobrien, Author at European Medical Journal

World map with the Middle East highlight with a red glowing dot

Supply chains and trials hit by Middle East instability

Pharma companies are facing renewed pressure due to instability linked to the Middle East conflict.

Month in pharma news, explained

Month in pharma news, explained – March 2026

In this roundup, we take a look back at top moments from the pharmaceutical industry from March.

Fountain pen signing a contract

Promotion of biologics under fire from FDA

The recent FDA letters to four biologics companies signal a continued rise in enforcement activity.

A women sitting next to a doctor clutching her abdomen

Gesynta’s endometriosis candidate enters phase 2

The study moves the non-hormonal endometriosis candidate into mid-stage testing in a field ripe for new options.

Plane flying over the Gulf but avoiding it

The Middle East conflict: pharma’s supply chain stress test

The conflict is disrupting critical air freight routes, exposing vulnerabilities for biologics and low-margin generics.

Women holding a clipboard

ABPI calls for NHS data use to boost trial recruitment

The NHS is sitting on a gold mine of patient data that could, in the ABPI’s view, help rescue the UK’s faltering clinical trials sector.

Hideki Garren on rethinking multiple sclerosis care

Hideki Garren explores how our understanding of MS is evolving, the challenge of measuring disease progression and what the future holds.

Hands holding model of a globe on a blue background

Progress on child mortality slows, UN report finds

Nearly 5 million children die annually from preventable causes linked to poor access to medicines.

Vaccine vials in a fridge

Fridge-free vaccine shows promise in early trial

A new fridge-free vaccine for tetanus and diphtheria has shown early promise in human trials.

A dollar note with pills and capsules

Survey: Half of US adults struggle to afford healthcare

The share of Americans who feel financially secure about paying for basic healthcare has fallen to its lowest level since 2021.